The following stocks are the leading risers and fallers on AIM in London on Wednesday.
----------
AIM - WINNERS
----------
Abingdon Health PLC, up 21% at 10.27 pence, 12-month range 4.00p-18.50p. The lateral flow test contract manufacturing firm rises on agreement with Boots. It says Boots are to sell its first own brand self-tests in stores and online across the UK provided by the Abingdon Health and Crest Medical partnership. It says that will made available from spring 2024. Chief Executive Chris Yates comments: ‘We are delighted to announce the launch of the Boots own-brand Iron and Vitamin D deficiency self-tests in conjunction with our partner Crest Medical. As lateral flow experts we’re proud to offer a comprehensive private label service to retailers covering a broad range of self-tests, including innovative exclusive products from Abingdon’s CDMO customers.’
----------
Strategic Minerals PLC, up 11.1% at 0.25p, 12-month range 0.080p-0.34p. The miner with projects in New Mexico, South Australia and the UK says that its whooly owned subsidiary Cornwall Resources Ltd has finalised an exclusivity and prospecting agreement with the Duchy of Cornwall. It says the agreement wil increase CRL’s footprint in the East Cornwall/Tamar Valley region almost fourfold. Chair Alan Broome says: ‘Strategic Minerals and CRL are honoured to be trusted to deliver progress in compliance with the Duchy of Cornwall’s strategic objectives. The CRL team is excited to progress initial reviews of the data and historical information available aimed at determining the design of the most logical work programs, with further announcements to follow.’
----------
AIM - LOSERS
----------
Versarien PLC, down 22% at 0.14p, 12-month range 0.070p-7.00p. The engineering technology company raises £615,000 through a placing of 492.0 million shares priced at 0.125p each. It says the proceeds will be used for corporate and working capital purposes as the Company continues to progress its turnaround strategy following the recent sale of its South Korean assets and licencing agreement with Montana Quimica LTDA. CEO Stephen Hodge says: ‘We are very pleased to have raised these funds which will facilitate further progress following the positive developments regarding the sale of the South Korean assets and licencing deal with Montana, and will assist in laying the foundations for us to implement a longer-term strategy for the business. We look forward to providing further updates in due course.’
----------
Copyright 2024 Alliance News Ltd. All Rights Reserved.
